Stay updated on Elsubrutinib & Upadacitinib in SLE Clinical Trial
Sign up to get notified when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.

Latest updates to the Elsubrutinib & Upadacitinib in SLE Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe record history shows a new revision v3.4.3 added, replacing the previous v3.4.2.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision entry v3.4.2 was added and the previous v3.4.1 entry was removed, reflecting a minor maintenance update to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedA new site revision (v3.4.1) has been added to the history, replacing the previous revision (v3.4.0).SummaryDifference0.1%

- Check73 days agoChange DetectedThe history page adds a Show glossary option and color-coded highlights for additions and deletions. It also updates the revision note to v3.4.0 and removes 'No FEAR Act Data'.SummaryDifference0.6%

- Check87 days agoChange DetectedA new revision label v3.3.4 was added to the history and the older label v3.3.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Elsubrutinib & Upadacitinib in SLE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.